SMAD2 and breast carcinoma: In addition, SMAD2/3 also participates in lipid metabolism in mouse hepatocytes (Yang et al., 2013) and epithelial-mesenchymal transition and metastasis induction in breast cancer (Rios Garcia et al., 2017).